Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Confirmation Process Hits A Roadblock: Time For Plan B?

This article was originally published in The Tan Sheet

Executive Summary

Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation appear to be in jeopardy after the Health Committee disclosed concerns about a conduct allegation lodged against the nominee

You may also be interested in...



Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold

The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground

Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold

The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground

Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold

The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground

Related Content

Topics

UsernamePublicRestriction

Register

PS098084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel